This inventor holds 1 USPTO granted patent. Top assignee: Obi Pharma Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Lee-Cheng Liu: Innovator in Protein Expression Technology
Introduction
Lee-Cheng Liu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the area of protein expression. His innovative work has led to advancements that are crucial for various applications in medicine and research.
Latest Patents
Lee-Cheng Liu holds a patent for the CRM197 protein expression. The present invention relates to a method for producing CRM197 recombinant protein in cells. This method comprises culturing a cell that contains an expression plasmid with a polynucleotide and inducing the expression of the CRM197 protein. This patent showcases his expertise and commitment to advancing biotechnological methods.
Career Highlights
Liu is associated with Obi Pharma Inc., a company that focuses on developing innovative therapies. His work at Obi Pharma has allowed him to collaborate with other talented professionals in the field. His contributions have been instrumental in pushing the boundaries of what is possible in protein expression technology.
Collaborations
Some of his notable coworkers include I-Ming Cho and Chia-Hung Chiu. Their collaborative efforts have further enhanced the research and development initiatives at Obi Pharma Inc.
Conclusion
Lee-Cheng Liu is a key figure in the field of protein expression, with a patent that highlights his innovative approach. His work continues to impact the biotechnology industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile